IP Library Granted Patent US 11,547,560
Granted Patent B2
US 11,547,560 · App. 15/478,210 · Granted Jan 10, 2023

Implantable cardiovascular valve

Inventors: Jose Luis Navia (Shaker Heights, OH); Ji-Feng Chen (Lakewood, OH)
Assignee: THE CLEVELAND CLINIC FOUNDATION
A61F2/2433A61F2/243A61F2/2418A61F2/2436A61F2/0095A61F2/2415A61F2/9522A61F2220/0008A61F2230/0078A61F2250/0092A61L27/3625A61L27/3629A61L27/3687A61L27/3691Y10T29/49925
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,547,560
App. No.
15/478,210
Granted
Jan 10, 2023
Kind
B2
Abstract

A method is provided for implanting a valve having at least one valve leaflet within the cardiovascular system of a subject. One step of the method includes preparing a substantially dehydrated bioprosthetic valve and then providing an expandable support member having oppositely disposed first and second ends and a main body portion extending between the ends. Next, the substantially dehydrated bioprosthetic valve is attached to the expandable support member so that the substantially dehydrated bioprosthetic valve is operably secured within the main body portion of the expandable support member. The expandable support member is then crimped into a compressed configuration and placed at a desired location within the cardiovascular system of the subject. Either before or after placement at the desired location, fluid or blood re-hydrates the substantially dehydrated bioprosthetic valve.

Claims (13)

1. A packaged device comprising:

an expandable heart valve comprising an annular expandable support member having a compressed and an expanded configuration and at least two strut members spaced apart from each other and affixed at the commissural section of a valve component such that at least two commissural sections are attached to one of the strut members, wherein the annular expandable support member is comprised of a stent comprised of a shape memory metal and oppositely disposed first and second ends and a main body portion extending therebetween secured to the valve component at the at least two strut members,

wherein the valve component is animal tissue having a surface comprised of interstices comprised of at least one dimensional stabilizer, selected from the group consisting of glycerol and derivatives of glycerol, and combinations thereof; and a layer of synthetic biocompatible material wrapped around an inner and an outer circumference of the annular expandable support member is sealed in an environment essentially free of liquid.

2. The packaged device of claim 1 , wherein the packaged device further comprises a delivery catheter wherein the expandable heart valve may be crimped about the periphery of a distal end of the catheter.

3. The packaged device of claim 2 , wherein the expandable heart valve is operably disposed about an inflatable balloon oriented at the distal end of the delivery catheter.

4. The packaged device of claim 3 , wherein the expandable heart valve is crimped around the inflatable balloon.

5. The packaged device of claim 1 wherein the layer of synthetic biocompatible material is attached about an entire circumference of the expandable support member.

6. The packaged device of claim 5 , wherein the synthetic biocompatible material is selected from the group consisting of: a polyester, woven velour, polyurethane, PTFE, ePTFE, and heparin-coated fabric.

7. The packaged device of claim 5 , wherein the layer of biocompatible material comprises interrupted sections.

8. The packaged device of claim 7 , wherein the animal tissue is selected from the group consisting of: bovine pericardium, equine pericardium, porcine pericardium, peritoneal tissue, and a cell-seeded tissue and combinations thereof.

9. The packaged device of claim 1 , further comprising an at least one of a radiographically opaque marking or a therapeutic agent associated with the expandable support member.

10. The packaged device of claim 1 , wherein the expandable support member is comprised of a continuous series of W-shaped segments.

11. The packaged device of claim 1 , wherein three valve leaflets of the valve component are joined together three commissural sections that are spaced apart from each other and attached to three strut members to prevent prolapse of the valve leaflets.

Assignments (2)
NUNC PRO TUNC ASSIGNMENT Recorded May 16, 2024
From: THE CLEVELAND CLINIC FOUNDATION
To: EDWARDS LIFESCIENCES CORPORATION
Reel/Frame 067429/0539 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 5, 2017
From: NAVIA, JOSE LUIS; CHEN, JI-FENG
To: THE CLEVELAND CLINIC FOUNDATION
Reel/Frame 044304/0351 →
Continuity (5)
Continuation 13868892 · Apr 23, 2013
Continuation 13336974 · Dec 23, 2011
Continuation 12016168 · Jan 17, 2008
Provisional Application 60881244 · Jan 19, 2007
Related Publication 20170266002A1 · Sep 21, 2017
Cited By (1)
US 12,318,291